« Back to Record
Citation APA

Kristeleit, R., Leary, A., Delord, J. P., Moreno, V., Oaknin, A., Castellano, D., Shappiro, G. G., Fernández, C., Kahatt, C., Alfaro, V., Siguero, M., Rueda, D., Zeaiter, A., Awada, A., Santaballa, A., Zaman, K., Sehouli, J., & Subbiah, V. (2023). Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study. Investigational new drugs, 41(5), 677-687. doi:10.1007/s10637-023-01383-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/372263

Kristeleit, R., Leary, A., Delord, J. P., Moreno, V., Oaknin, A., Castellano, D., Shappiro, G. G., Fernández, C., Kahatt, C., Alfaro, V., Siguero, M., Rueda, D., Zeaiter, A., Awada, A., Santaballa, A., Zaman, K., Sehouli, J., & Subbiah, V. (2023). Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study. Investigational new drugs, 41(5), 677-687. doi:10.1007/s10637-023-01383-2